Glycogen synthase kinase-3 (GSK-3) is a crucial regulator of cardiac hypertrophy, and 2,5-dimethylcelecoxib (DM-celecoxib) was found to activate Grb2 tyrosine phosphorylated during the aging process stimulated by CD4. This evidence concerns the gene GRB2 and cardiac hypertrophy.